Abstract
Rheumatoid Arthritis (RA) is a complex systemic autoimmune disease in which various cell types are involved. Among them, neutrophils have been recognized as important players in the onset and the progression of RA. The pathogenic role of neutrophils in RA lies in the alteration of several processes, including increased cell survival and migratory capacity, abnormal inflammatory activity, elevated oxidative stress and an exacerbated release of neutrophil extracellular traps. Through these mechanisms, neutrophils can activate other immune cells, thus perpetuating inflammation and leading to the destruction of the cartilage and bone of the affected joint. Given the considerable contribution of neutrophils to the pathophysiology of RA, several studies have attempted to clarify the effects of various therapeutic agents on this subtype of leukocyte. To date, recent studies have envisaged the role of new molecules on the pathogenic profile of neutrophils in RA, which could represent novel targets in future therapies. In this review, we aim to review the pathogenic role of neutrophils in RA, the effect of conventional treatments and biologic therapies, and the new, potential targets of neutrophil-derived molecules for the treatment of RA.
Citations
Jun 23, 2020·Cell Proliferation·Danyi XuChaohui Yu
Apr 24, 2020·Molecular Medicine Reports·Xinqiang SongErqin Dai
May 30, 2019·Aging·Guoqing LiDan Liu
Jul 22, 2020·Aging·Yingjie WangXisheng Weng
Sep 3, 2019·Frontiers in Pharmacology·Yaqi KangJianming Wu
Dec 2, 2019·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Lucinéia Reuse AlbieroYara Maria Lucisano-Valim
Sep 4, 2020·Journal of Immunology Research·Delou PaiBenedikt Trabold
Sep 10, 2020·International Journal of Molecular Sciences·Patrick T San GabrielBelal Chami
Jun 7, 2019·Clinical Reviews in Allergy & Immunology·Carlo Selmi
Mar 31, 2020·Bulletin of Mathematical Biology·A BayaniM R Nelson
Oct 17, 2019·International Journal of Molecular Sciences·Xiaohong LiAnlong Xu
Nov 3, 2020·PLoS Computational Biology·Anahita BayaniMartin R Nelson
Dec 3, 2020·International Journal of Molecular Sciences·Chary Lopez-PedreraCarlos Pérez-Sánchez
Dec 3, 2020·Life·Chih-Chao ChiangTsong-Long Hwang
Jan 24, 2020·International Immunopharmacology·Xinqiang SongHongtao Du
May 7, 2020·European Polymer Journal·Elina KiblerSergei Tverdokhlebov
Mar 18, 2021·Scientific Reports·Adéla NavrátilováLucie Andrés Cerezo
Jul 18, 2020·The Journal of Nutritional Biochemistry·Kai YuanAnlong Xu
Apr 9, 2020·Journal of Ethnopharmacology·Felipe Marques TeixeiraSônia Soares Costa
Aug 17, 2020·Biomedical Journal·Maria I EdilovaAli A Abdul-Sater
May 18, 2021·Frontiers in Pharmacology·Franciel Batista FelixVanessa Pinho
Jul 2, 2021·Journal of Family Medicine and Primary Care·Kaushik MukhopadhyayMitali Chatterjee
Apr 11, 2020·Journal of Agricultural and Food Chemistry·Yan ZhangGang Jin
Aug 17, 2019·Journal of Natural Products·Min ZhaoLi-Juan Chen
Jan 15, 2019·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Ruchi YadavBalázs Rada
May 10, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Rui WangWei Wei
Sep 25, 2021·Immunology·Hong-Yu LiangWei Hu